This document is an excerpt from the EUR-Lex website
Document 62017TN0587
Case T-587/17: Action brought on 28 August 2017 — Unigroup v EUIPO — Pronova Laboratories (nailicin)
Case T-587/17: Action brought on 28 August 2017 — Unigroup v EUIPO — Pronova Laboratories (nailicin)
Case T-587/17: Action brought on 28 August 2017 — Unigroup v EUIPO — Pronova Laboratories (nailicin)
OJ C 347, 16.10.2017, pp. 48–48
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
16.10.2017 |
EN |
Official Journal of the European Union |
C 347/48 |
Action brought on 28 August 2017 — Unigroup v EUIPO — Pronova Laboratories (nailicin)
(Case T-587/17)
(2017/C 347/63)
Language in which the application was lodged: English
Parties
Applicant: Unigroup ApS (Lyngby, Denmark) (represented by: M. Rijsdijk, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Pronova Laboratories BV (Amsterdam, Netherlands)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant
Trade mark at issue: EU word mark ‘nailicin’ — Application for registration No 14 096 499
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the fifth Board of Appeal of EUIPO of 9 June 2017 in Case R 2359/2016-5
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
declare Benelux registration no. 894 557 unsubstantiated and remit the matter to the Opposition Division or Board of Appeal of EUIPO; |
|
— |
order EUIPO to pay the costs. |
Plea in law
|
— |
violation of Rule 19 of Commission Regulation No 2868/95 implementing Council Regulation No 40/94 on the Community trade mark. |